DK1321139T3 - 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte - Google Patents

2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte

Info

Publication number
DK1321139T3
DK1321139T3 DK01130638T DK01130638T DK1321139T3 DK 1321139 T3 DK1321139 T3 DK 1321139T3 DK 01130638 T DK01130638 T DK 01130638T DK 01130638 T DK01130638 T DK 01130638T DK 1321139 T3 DK1321139 T3 DK 1321139T3
Authority
DK
Denmark
Prior art keywords
indanylamino
treatment
derivatives
chronic
acute
Prior art date
Application number
DK01130638T
Other languages
English (en)
Inventor
Claudio Pietra
Gino Villetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of DK1321139T3 publication Critical patent/DK1321139T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01130638T 2001-12-21 2001-12-21 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte DK1321139T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01130638A EP1321139B1 (en) 2001-12-21 2001-12-21 2-Indanylamino deratives for the therapy of chronic, acute or inflammatory pain

Publications (1)

Publication Number Publication Date
DK1321139T3 true DK1321139T3 (da) 2007-01-02

Family

ID=8179649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01130638T DK1321139T3 (da) 2001-12-21 2001-12-21 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte

Country Status (18)

Country Link
US (1) US20050222266A1 (da)
EP (2) EP1321139B1 (da)
JP (1) JP4427329B2 (da)
AT (1) ATE336990T1 (da)
BR (1) BR0207371A (da)
CA (1) CA2470990C (da)
DE (1) DE60122541T2 (da)
DK (1) DK1321139T3 (da)
ES (1) ES2270947T3 (da)
HU (1) HUP0402664A3 (da)
MX (1) MXPA04005884A (da)
NO (1) NO20033670L (da)
NZ (1) NZ533537A (da)
PL (1) PL207015B1 (da)
PT (1) PT1321139E (da)
SI (1) SI1321139T1 (da)
WO (1) WO2003053429A2 (da)
ZA (1) ZA200404845B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ565416A (en) * 2005-07-28 2011-03-31 Chiesi Farma Spa Therapeutic combination comprising a NMDA receptors blocker and a narcotic analgesic substance
WO2012112969A1 (en) 2011-02-18 2012-08-23 Endo Pharmaceuticals Inc. Aminoindane compounds and use thereof in treating pain
WO2014028675A1 (en) 2012-08-15 2014-02-20 Endo Pharmaceuticals Inc. Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
EP0980247A1 (en) * 1997-05-07 2000-02-23 Algos Pharmaceutical Corporation Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
WO2000076510A1 (en) * 1999-06-10 2000-12-21 Bridge Pharma, Inc. Dermal anesthetic agents

Also Published As

Publication number Publication date
ZA200404845B (en) 2006-07-26
CA2470990C (en) 2011-03-29
WO2003053429A3 (en) 2003-07-31
EP1321139A1 (en) 2003-06-25
PL370763A1 (en) 2005-05-30
BR0207371A (pt) 2004-02-10
CA2470990A1 (en) 2003-07-03
EP1455771A2 (en) 2004-09-15
JP4427329B2 (ja) 2010-03-03
NZ533537A (en) 2006-08-31
SI1321139T1 (sl) 2007-02-28
DE60122541D1 (de) 2006-10-05
MXPA04005884A (es) 2004-11-01
AU2002366727A1 (en) 2003-07-09
WO2003053429A2 (en) 2003-07-03
US20050222266A1 (en) 2005-10-06
NO20033670L (no) 2003-10-21
ATE336990T1 (de) 2006-09-15
EP1455771B1 (en) 2006-11-08
NO20033670D0 (no) 2003-08-19
HUP0402664A3 (en) 2012-05-29
EP1321139B1 (en) 2006-08-23
PT1321139E (pt) 2007-01-31
JP2005513101A (ja) 2005-05-12
DE60122541T2 (de) 2007-09-13
HUP0402664A2 (hu) 2005-04-28
ES2270947T3 (es) 2007-04-16
PL207015B1 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
EA200201012A1 (ru) Способы стерилизации биологических материалов
DE60327618D1 (de) Gegen iap gerichtete antisense-nukleobasen und deren verwendungen
ATE552854T1 (de) Gezielte biozide
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
DE60323077D1 (de) Immobilisierung und stabilisierung von viren
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
TW200733953A (en) Materials and methods for treating viral infections
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
BRPI0514720A (pt) combinações herbicidas com ceto-enóis especiais
UY29424A1 (es) N-(4-piridilalquil) metilsulfonamidas para combatir pestes artrópodos
DE602006014138D1 (de) Sicherheitsverbesserte elektrode durch einführung von vernetzbarem polymer und elektrochemische einrichtung damit
CO5640121A2 (es) Un metodo de tratamiento de un trastorno de la ansiedad
BR0317398A (pt) Concentrados de microemulsão
BR0309628A (pt) fibras e estruturas planas têxteis acabadas
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
DK1321139T3 (da) 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte
BR0201877A (pt) Decodificador em treliças e equalizador de realimentação de decisão combinados
DK1765370T3 (da) Parapox-vira i kombination med andre antivirale midler til behandling af HIV/AIDS
BR0314716A (pt) Anticorpos de subunidade alfa de lfa-1 e métodos de uso
DE602004019558D1 (de) Atmosphärische plasmabehandlung von meltblown-fasern, die bei der filtration verwendet werden
ATE452996T1 (de) Nachweis von hiv-typen und hiv-subtypen
CU23309B7 (es) Compuestos anã logos de astrobilurinas y su uso como acaricida e insecticida
ATE371461T1 (de) Verwendung von extrakten aus wurzeln von pelargonium sidoides und/oder pelargonium reniforme
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
EA200301151A1 (ru) Вакцина против натуральной оспы